Suppression of Tumor Angiogenesis Through the Inhibition of Integrin Function and Signaling in Endothelial Cells: Which Side to Target?

References

• Akre K., Ekstrom A.M., Signorello L.B., Hansson L.E., and Nyren O. (2001) Aspirin and risk for gastric cancer: A population-based case-control study in Sweden. British Journal of Cancer, 84, 965–968.
   Google Scholar
• Aoudjit F, and Vuori K. (2001) Matrix attachment regulates Fas-induced apoptosis in endothelial cells: A role for c-Flip and implications for anoikis. Journal of Cell Biology, 152, 633–643.
   Google Scholar
• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R., Li T, Witzenbichler B, Schatteman G, and Isner J.M.. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964–967.
   Google Scholar
• Attwell S, Roskelley C, and Dedhar S. (2000) The integrin-linked kinase (ILK) suppresses anoikis. Oncogene, 19, 3811–3815.
   Google Scholar
• Bader B.L., Rayburn H, Crowley D, and Hynes R.O.. (1998) Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell, 95, 507–519.
   Google Scholar
• Bello L, Francolini M, Marthyn P, Zhang J, Carroll R.S., Nikas D.C., Strasser J.F., Villani R, Cheresh D.A., and Black P.M.. (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery, 49, 380–389; discussion 390.
   Google Scholar
• Boehm-Viswanathan T. (2000) Is angiogenesis inhibition the Holy Grail of cancer therapy? Current Opinion in Oncology, 12, 89–94.
   PubMed Web of Science ®Google Scholar
• Boger D.L., Goldberg J., Silletti S., Kessler T., and Cheresh D.A. (2001) Identi?cation of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3). Journal of the American Chemical Society, 123, 1280–1288.
   PubMed Web of Science ®Google Scholar
• Brooks P.C., Clark R.A., and Cheresh D.A. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science, 264, 569–571.
   PubMed Web of Science ®Google Scholar
• Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., and Cheresh D.A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157– 1164.
   PubMed Web of Science ®Google Scholar
• Brooks P.C., Stromblad S., Klemke R., Visscher D., Sarkar F.H., and Cheresh D.A. (1995) Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. Journal of Clinical Investigation, 96, 1815– 1822.
   PubMed Web of Science ®Google Scholar
• Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., and Cheresh D.A. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell, 85, 683–693.
   PubMed Web of Science ®Google Scholar
• Burridge K., Chrzanowska-Wodnicka M., and Zhong C. (1997) Focal adhesion assembly. Trends in Cell Biology, 7, 342–347.
   PubMed Web of Science ®Google Scholar
• Byzova T.V., Goldman C.K., Pampori N., Thomas K.A., Bett A., Shattil S.J., and Plow E.F. (2000) A mechanism for modulation of cellular responses to VEGF: Activation of the integrins. Molecular Cell, 6, 851–860.
   PubMed Web of Science ®Google Scholar
• Cardone M.H., Salvesen G.S., Widmann C., Johnson G., and Frisch S.M. (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell, 90, 315–323.
   PubMed Web of Science ®Google Scholar
• Carmeliet P., and Jain R.K. (2000) Angiogenesis in cancer and other diseases. Nature, 407, 249–257.
   PubMed Web of Science ®Google Scholar
• Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Science USA, 72, 3666–3670.
   PubMed Web of Science ®Google Scholar
• Cheresh D.A. (1987) Human endothelial cells synthesize and express an ArgGly-Asp-directed adhesion receptor involved in attachment to ?brinogen and von Willebrand factor. Proceedings of the National Academy of Science USA, 84, 6471–6475.
   PubMed Web of Science ®Google Scholar
• Cheresh D.A., and Stupack D.G. (2002) Integrin-mediated death: An explanation of the integrin-knockout phenotype? Nature Medicine, 8, 193–194.
   PubMed Web of Science ®Google Scholar
• Coleman R.A., Smith W.L., and Narumiya S. (1994) International Union of Pharmacology classi?cation of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacology Review, 46, 205–229.
   PubMed Web of Science ®Google Scholar
• Collo G., and Pepper M.S. (1999) Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. Journal of Cellular Science, 112, 569–578.
   PubMed Web of Science ®Google Scholar
• Compagni A., and Christofori G. (2000) Recent advances in research on multistage tumorigenesis. British Journal of Cancer, 83, 1–5.
   PubMed Web of Science ®Google Scholar
• D’Angelo G., Lee H., and Weiner R.I. (1997) cAMP-Dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and ?broblast growth factor in capillary endothelial cells by blocking Raf activation. Journal of Cellular Biochemistry, 67, 353–366.
   PubMed Web of Science ®Google Scholar
• Datta S.R., Brunet A., and Greenberg M.E. (1999) Cellular survival: A play in three Akts. Genes and Development, 13, 2905–2927.
   PubMed Web of Science ®Google Scholar
• Day M.L., Foster R.G., Day K.C., Zhao X., Humphrey P., Swanson P., Postigo A.A., Zhang S.H., and Dean D.C. (1997) Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. Journal of Biological Chemistry, 272, 8125–8128.
   PubMed Web of Science ®Google Scholar
• Dechantsreiter M.A., Planker E., Matha B., Lohof E., Holzemann G., Jonczyk A., Goodman S.L., and Kessler H. (1999) <I>N</I>-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. Journal of Medicinal Chemistry, 42, 3033–3040.
   PubMed Web of Science ®Google Scholar
• Dignat-George F., Blann A., and Sampol J. (2000) Circulating endothelial cells in acute coronary syndromes. Blood, 95, 728.
   PubMed Web of Science ®Google Scholar
• Dormond O., Foletti A., Paroz C., and Ruegg C. (2001) NSAIDs inhibit alphaVbeta3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nature Medicine, 7, 1041–1047.
   PubMed Web of Science ®Google Scholar
• Dormond O., Lejeune F., and R¨uegg C. (2002) TNF and IFNgamma induced G1/S block in human endothelial cells is associated with expression of p16INK4a. Anticancer Research. In press.
   Google Scholar
• Dormond O, and R¨uegg C. (2001) Inhibition of tumor angiogenesis by nonsteroidal anti-in?ammatory drugs: Emerging mechanisms and therapeutic perspectives. Drug Resistance Updates, 4, 314–321.
   PubMed Web of Science ®Google Scholar
• Eigenthaler M., Hofferer L., Shattil S.J., and Ginsberg M.H. (1997) A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its speci?c interaction with beta3-endonexin. Journal of Biological Chemistry, 272, 7693–7698.
   PubMed Web of Science ®Google Scholar
• Eliceiri B.P., and Cheresh D.A. (2000) Role of alpha V integrins during angiogenesis. Cancer Journal, 6, S245–S249.
   PubMed Web of Science ®Google Scholar
• Eliceiri B.P., Klemke R., Stromblad S., and Cheresh D.A. (1998) Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. Journal of Cell Biology, 140, 1255–1263.
   PubMed Web of Science ®Google Scholar
• Eliceiri B.P., Puente X.S., Hood J.D., Stupack D.G., Schlaepfer D.D., Huang X.Z., Sheppard D., and Cheresh D.A. (2002) Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. Journal of Cell Biology, 157, 149–160.
   PubMed Web of Science ®Google Scholar
• Evers E.E., Zondag G.C., Malliri A., Price L.S., ten Klooster J.P., van der Kammen R.A., and Collard J.G. (2000) Rho family proteins in cell adhesion and cell migration. European Journal of Cancer, 36, 1269–1274.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1971) Tumor angiogenesis: Therapeutical implications. New England Journal of Medicine, 285, 1182–1186.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27–31.
   PubMed Web of Science ®Google Scholar
• Folkman J., Watson K., Ingber D., and Hanahan D. (1989) Induction of angiogenesis during the transition for hyperplasia to neoplasia. Nature, 339, 58–61.
   PubMed Web of Science ®Google Scholar
• Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., and Cheresh D.A. (1995) De?nition of two angiogenic pathways by distinct alpha v integrins. Science, 270, 1500–1502.
   PubMed Web of Science ®Google Scholar
• Frisch S.M., and Francis H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. Journal of Cell Biology, 124, 619–626.
   PubMed Web of Science ®Google Scholar
• Frisch S.M., and Ruoslahti E. (1997) Integrins and anoikis. Current Opinion in Cell Biology, 9, 701–706.
   PubMed Web of Science ®Google Scholar
• Frisch S.M., Vuori K., Kelaita D., and Sicks S. (1996) A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. Journal of Cell Biology, 135, 1377–1382.
   PubMed Web of Science ®Google Scholar
• Gabrilovich D.I., Ishida T., Nadaf S., Ohm J.E., and Carbone D.P. (1999) Antibodies to vascular endothelial growth factor enhance the ef?cacy of cancer immunotherapy by improving endogenous dendritic cell function. Clinical Cancer Research, 5, 2963–2970.
   PubMed Web of Science ®Google Scholar
• Galbraith S.M., Chaplin D.J., Lee F., Stratford M.R., Locke R.J., Vojnovic B., and Tozer G.M. (2001) Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. Anticancer Research, 21, 93–102.
   PubMed Web of Science ®Google Scholar
• Giancotti F.G., and Ruoslahti E. (1999) Transduction—Integrin signaling. Science, 285, 1028–1032.
   PubMed Web of Science ®Google Scholar
• Giardiello F.M., Hamilton S.R., Krush A.J., Piantadosi S., Hylind L.M., Celano P., Booker S.V., Robinson C.R., and Offerhaus G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New England Journal of Medicine, 328, 1313–1316.
   PubMed Web of Science ®Google Scholar
• Gorski D.H., Mauceri H.J., Salloum R.M., Gately S., Hellman S., Beckett M.A., Sukhatme V.P., Soff G.A., Kufe D.W., and Weichselbaum R.R. (1998) Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Research, 58, 5686–5689.
   PubMed Web of Science ®Google Scholar
• Grif?oen A.W., and Molema G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic in?ammation. Pharmacological Reviews, 52, 237–268.
   PubMed Web of Science ®Google Scholar
• Gupta R.A., and DuBois R.N. (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Cancer Reviews, 1, 11–21.
   PubMed Web of Science ®Google Scholar
• Gutheil J.C., Campbell T.N., Pierce P.R., Watkins J.D., Huse W.D., Bodkin D.J., and Cheresh D.A. (2000) Targeted antiangiogenic therapy for cancer using Vitaxin: A humanized monoclonal antibody to the integrin alphavbeta3. Clinical Cancer Research, 6, 3056–3061.
   PubMed Web of Science ®Google Scholar
• Hammes H.P., Brownlee M., Jonczyk A., Sutter A., and Preissner K.T. (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Medicine, 2, 529–533.
   Google Scholar
• Hanahan D, and Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353–364.
   PubMed Web of Science ®Google Scholar
• Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., and Wiegand S.J. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science, 284, 1994–1998.
   PubMed Web of Science ®Google Scholar
• Holmgren L., O’Reilly M.S., and Folkman J. (1995) Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine, 1, 149–153.
   PubMed Web of Science ®Google Scholar
• Huang X., Molema G., King S., Watkins L., Edgington T.S., and Thorpe P.E. (1997) Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science, 275, 547–550.
   PubMed Web of Science ®Google Scholar
• Hynes R.O. (1999) Cell adhesion: Old and new questions. Trends in Cell Biology, 9, M33–M37.
   PubMed Web of Science ®Google Scholar
• Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., and Yamamoto T. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-de?cient mice. Nature, 377, 539–544.
   PubMed Web of Science ®Google Scholar
• Jones M.K., Wang H., Peskar B.M., Levin E., Itani R.M., Sarfeh I.J., and Tarnawski A.S. (1999) Inhibition of angiogenesis by nonsteroidal antiin?ammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nature Medicine, 5, 1418–1423.
   PubMed Web of Science ®Google Scholar
• Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., and Asahara T. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Science USA, 97, 3422–3427.
   PubMed Web of Science ®Google Scholar
• Kerbel R.S. (2000) Tumor angiogenesis: Past, present and the near future. Carcinogenesis, 21, 505–515.
   Google Scholar
• Kerbel R.S., Viloria-Petit A., Okada F, and Rak J. (1998) Establishing a link between oncogenes and tumor angiogenesis. Molecular Medicine, 4, 286–295.
   PubMed Web of Science ®Google Scholar
• Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P.H., and Downward J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO Journal, 16, 2783–2793.
   PubMed Web of Science ®Google Scholar
• Kim S., Bell K., Mousa S.A., and Varner J.A. (2000) Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of ?bronectin. American Journal of Pathology, 156, 1345–1362.
   PubMed Web of Science ®Google Scholar
• Kim S., Harris M., and Varner J.A. (2000) Regulation of integrin alpha vbeta 3mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. Journal of Biological Chemistry, 275, 33920–33928.
   PubMed Web of Science ®Google Scholar
• Klinghoffer R.A., Sachsenmaier C., Cooper J.A., and Soriano P. (1999) Src family kinases are required for integrin but not PDGFR signal transduction. EMBO Journal, 18, 2459–2471.
   PubMed Web of Science ®Google Scholar
• Kolanus W., and Seed B. (1997) Integrins and inside-out signal transduction: Converging signals from PKC and PIP3. Current Opinion in Cell Biology, 9, 725–731.
   PubMed Web of Science ®Google Scholar
• LaFlamme S.E., Thomas L.A., Yamada S.S., and Yamada K.M. (1994) Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly. Journal of Cell Biology, 126, 1287–1298.
   PubMed Web of Science ®Google Scholar
• Leavesley D.I., Schwartz M.A., Rosenfeld M., and Cheresh D.A. (1993) Integrin beta 1-and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. Journal of Cell Biology, 121, 163–170.
   PubMed Web of Science ®Google Scholar
• Lee J.W., and Juliano R.L. (2000) Alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Molecular Biology of the Cell, 11, 1973–1987.
   PubMed Web of Science ®Google Scholar
• Lejeune F., R¨uegg C., and Li´enard D. (1998) Clinicalapplications of TNF-alpha in cancer. Current Opinion in Immunology, 10, 573–580.
   PubMed Web of Science ®Google Scholar
• Lienard D., Ewalenko P., Delmotte J.J., Renard N., and Lejeune F.J. (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. Journal of Clinical Oncology, 10, 52–60.
   PubMed Web of Science ®Google Scholar
• Liu K.Y., Timmons S., Lin Y.Z., and Hawiger J. (1996) Identi?cation of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. Proceedings of the National Academy of Science USA, 93, 11819–11824.
   PubMed Web of Science ®Google Scholar
• Lode H.N., Moehler T., Xiang R., Jonczyk A., Gillies S.D., Cheresh D.A., and Reisfeld R.A. (1999) Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proceedings of the National Academy of Science USA, 96, 1591–1596.
   PubMed Web of Science ®Google Scholar
• Lopez-Marure R., Ventura J.L., Sanchez L., Montano L.F., and Zentella A. (2000) Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. European Journal of Biochemistry, 267, 4325–4333.
   PubMedGoogle Scholar
• Lukashev M.E., Sheppard D., and Pytela R. (1994) Disruption of integrin function and induction of tyrosine phosphorylation by the autonomously expressed beta 1 integrin cytoplasmic domain. Journal of Biological Chemistry, 269, 18311–18314.
   PubMed Web of Science ®Google Scholar
• Lund E.L., Bastholm L., and Kristjansen P.E. (2000) Therapeutic synergy of TNP-470 and ionizing radiation: Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Clinical Cancer Research, 6, 971–978.
   PubMed Web of Science ®Google Scholar
• Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., and Ra?i S. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine, 7, 1194–1201.
   PubMed Web of Science ®Google Scholar
• Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O’Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K., and Benezra R. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670–677.
   PubMed Web of Science ®Google Scholar
• MacDonald T.J., Taga T., Shimada H., Tabrizi P., Zlokovic B.V., Cheresh D.A., and Laug W.E. (2001) Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery, 48, 151–157.
   PubMed Web of Science ®Google Scholar
• Makimoto H., Koizumi K., Tsunoda S., Wakai Y., Matsui J., Tsutsumi Y., Nakagawa S., Ohizumi I., Taniguchi K., Saito H., Utoguchi N., Ohsugi Y., and Mayumi T. (1999) Tumor vascular targeting using a tumor-tissue endothelium-speci?c monoclonal antibody as an effective strategy for cancer chemotherapy. Biochemical Biophysical Research Communications, 260, 346–350.
   PubMed Web of Science ®Google Scholar
• Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., and Bertolini F. (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97, 3658–3661.
   PubMed Web of Science ®Google Scholar
• Max R., Gerritsen R.R., Nooijen P.T., Goodman S.L., Sutter A., Keilholz U., Ruiter D.J., and De Waal R.M. (1997) Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. International Journal of Cancer, 71, 320–324.
   PubMed Web of Science ®Google Scholar
• Meredith J., Jr., Fazeli B., and Schwartz M.A. (1993) The extracellular matrix as a cell survival factor. Molecular Biology of the Cell, 4, 953–961.
   PubMed Web of Science ®Google Scholar
• Miranti C.K., and Brugge J.S. (2002) Sensing the environment: A historical perspective on integrin signal transduction. Nature Cell Biology, 4, 83–90.
   PubMed Web of Science ®Google Scholar
• Murohara T., Horowitz J.R., Silver M., Tsurumi Y., Chen D., Sullivan A., and Isner J.M. (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97, 99–107.
   PubMed Web of Science ®Google Scholar
• Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., and Imaizumi T. (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation, 105, 1527–1536.
   PubMed Web of Science ®Google Scholar
• Nilsson F., Kosmehl H., Zardi L., and Neri D. (2001) Targeted delivery of tissue factor to the ED-B domain of ?bronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Research, 61, 711–716.
   PubMed Web of Science ®Google Scholar
• Oguey D., George P.W., and R¨uegg C. (2000) Disruption of integrin-dependent adhesion and survival of endothelial cells by recombinant adenovirus expressing isolated beta integrin cytoplasmic domains. Gene Therapy, 7, 1292–1303.
   PubMed Web of Science ®Google Scholar
• O’Reilly M.S., Holmgren L., Chen C., and Folkman J. (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Medicine, 2, 689–692.
   PubMed Web of Science ®Google Scholar
• O’Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments]. Cell, 79, 315–328.
   PubMed Web of Science ®Google Scholar
• Pasqualini R., Koivunen E., and Ruoslahti E. (1997) Alpha v integrins as receptors for tumor targeting by circulating ligands. Nature Biotechnology, 15, 542–546.
   PubMed Web of Science ®Google Scholar
• Paul R., Zhang Z.G., Eliceiri B.P., Jiang Q., Boccia A.D., Zhang R.L., Chopp M., and Cheresh D.A. (2001) Src de?ciency or blockade of Src activity in mice provides cerebral protection following stroke. Nature Medicine, 7, 222–227.
   PubMed Web of Science ®Google Scholar
• Posey J.A., Khazaeli M.B., DelGrosso A., Saleh M.N., Lin C.Y., Huse W., and LoBuglio A.F. (2001) A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer. Cancer Biotherapy Radiopharmaceutics, 16, 125–132.
   PubMed Web of Science ®Google Scholar
• Re F., Zanetti A., Sironi M., Polentarutti N., Lanfrancone L., Dejana E., and Colotta F. (1994) Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. Journal of Cell Biology, 127, 537–546.
   PubMed Web of Science ®Google Scholar
• Reynolds L.E., Wyder L., Lively J.C., Taverna D., Robinson S.D., Huang X., Sheppard D., Hynes R.O., and Hodivala-Dilke K.M. (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nature Medicine, 8, 27–34.
   PubMed Web of Science ®Google Scholar
• Risau W. (1997) Mechanisms of angiogenesis. Nature, 386, 671–674.
   PubMed Web of Science ®Google Scholar
• R¨uegg C., Yilmaz A., Bieler G., Bamat J., Chaubert P., and Lejeune F.J. (1998) Evidence for the involvement of endothelial cell integrin alpha-v-beta-3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nature Medicine, 4, 408–414.
   PubMed Web of Science ®Google Scholar
• Scatena M., Almeida M., Chaisson M.L., Fausto N., Nicosia R.F., and Giachelli C.M. (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. Journal of Cell Biology, 141, 1083–1093.
   PubMed Web of Science ®Google Scholar
• Schiller J.H., and Bittner G. (1999) Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: Effects on tumor neovascularization. Clinical Cancer Research, 5, 4287– 4294.
   PubMed Web of Science ®Google Scholar
• Schnitzer J.E. (1998) Vascular targeting as a strategy for cancer therapy. New England Journal of Medicine, 339, 472–474.
   PubMed Web of Science ®Google Scholar
• Schwartz M.A., Schaller M.D., and Ginsberg M.H. (1995) Integrins: Emerging paradigms of signal transduction. Annual Review of Cell and Developmental Biology, 11, 549–599.
   PubMed Web of Science ®Google Scholar
• Shalinsky D.R., Brekken J., Zou H., Bloom L.A., McDermott C.D., Zook S., Varki N.M., and Appelt K. (1999) Marked antiangiogenic and antitumor ef?cacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: Single agent and combination chemotherapy studies. Clinical Cancer Research, 5, 1905–1917.
   PubMed Web of Science ®Google Scholar
• Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage L.R., Moore M.A., Storb R.F., and Hammond W.P.. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood, 92, 362–367.
   Google Scholar
• Shiff S.J., and Rigas B. (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiin?ammatory drugs (NSAIDs). Journal of Experimental Medicine, 190, 445–450.
   PubMed Web of Science ®Google Scholar
• Sieg D.J., Hauck C.R., and Schlaepfer D.D. (1999) Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. Journal of Cellular Science, 112, 2677–2691.
   PubMed Web of Science ®Google Scholar
• Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., and Li K. (1998) Detection of tumor angiogenesis in vivo by alpha V beta 3-targeted magnetic resonance imaging. Nature Medicine, 4, 623–626.
   PubMedGoogle Scholar
• Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., and Detmar M. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Medicine, 7, 192–198.
   PubMed Web of Science ®Google Scholar
• Soldi R., Mitola S., Strasly M., Deflippi P., Tarone G, and Bussolino F. (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO Journal, 18, 882–892.
   Google Scholar
• Solovey A., Lin Y., Browne P., Choong S., Wayner E., and Hebbel R.P. (1997) Circulating activated endothelial cells in sickle cell anemia. New England Journal of Medicine, 337, 1584–1590.
   PubMed Web of Science ®Google Scholar
• Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., and Achen M.G. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Medicine, 7, 186–191.
   PubMed Web of Science ®Google Scholar
• Stromblad S., Becker J.C., Yebra M., Brooks P.C., and Cheresh D.A. (1996) Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. Journal of Clinical Investigation, 98, 426–433.
   PubMed Web of Science ®Google Scholar
• Stromblad S., Fotedar A., Brickner H., Theesfeld C., Aguilar de Diaz E., Friedlander M, and Cheresh D.A.. (2002) Loss of p53 compensates for alpha v-integrin function in retinal neovascularization. Journal of Biological Chemistry, 277, 13371–13374.
   Google Scholar
• Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., and Cheresh D.A. (2001) Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. Journal of Cell Biology, 155, 459–470.
   PubMed Web of Science ®Google Scholar
• Takahashi Y., Bucana C.D., Cleary K.R., and Ellis L.M. (1998) P53, vessel count, and vascular endothelial growth factor expression in human colon cancer. International Journal of Cancer, 79, 34–38.
   PubMed Web of Science ®Google Scholar
• Taverna D., and Hynes R.O. (2001) Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies. Cancer Research, 61, 5255–5261.
   PubMed Web of Science ®Google Scholar
• Thun M.J., Namboodiri M.M., and Heath C.W., Jr. (1991) Aspirin use and reduced risk of fatal colon cancer. New England Journal of Medicine, 325, 1593–1596.
   PubMed Web of Science ®Google Scholar
• Troussard A.A., Costello P., Yoganathan T.N., Kumagai S., Roskelley C.D., and Dedhar S. (2000) The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene, 19, 5444–5452.
   PubMed Web of Science ®Google Scholar
• Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705–716.
   PubMed Web of Science ®Google Scholar
• Vane J.R., Bakhle Y.S., and Botting R.M. (1998) Cyclooxygenases 1 and 2. Annual Review of Pharmacology and Toxicology, 38, 97–120.
   PubMed Web of Science ®Google Scholar
• Varner J.A., and Cheresh D.A. (1996) Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important Advances in Oncology, 2, 69–87.
   Google Scholar
• Vassalli G., Oguey D., Bamat J., Paroz C., and R¨uegg C. (2001) Induction of endothelial cells detachment and apoptosis by intravascular delivery of recombinant adenovirus expressing isolated b1 integrin cytoplasmic domain. Submitted.
   Google Scholar
• Weidner N, Semple J.P., Welch W.R., and Folkman J. (1991) Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. New England Journal of Medicine, 324, 1–8.
   PubMed Web of Science ®Google Scholar
• Welsh C.F., and Assoian R.K. (2000) A growing role for Rho family GTPases as intermediaries in growth factor-and adhesion-dependent cell cycle progression. Biochimica Biophysica Acta, 1471, M21–M29.
   PubMed Web of Science ®Google Scholar
• Williams C.S., Mann M., and DuBois R.N. (1999) The role of cyclooxygenases in in?ammation, cancer, and development. Oncogene, 18, 7908–7916.
   PubMed Web of Science ®Google Scholar
• Williams C.S., Tsujii M., Reese J., Dey S.K., and DuBois R.N. (2000) Host cyclooxygenase-2 modulates carcinoma growth. Journal of Clinical Investigation, 105, 1589–1594.
   PubMed Web of Science ®Google Scholar
• Xia Z., Dickens M., Raingeaud J., Davis R., and Greenberg M. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326– 1331.
   PubMed Web of Science ®Google Scholar
• Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., and Arnaout M.A. (2001) Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science, 294, 339–345.
   PubMed Web of Science ®Google Scholar
• Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., and Arnaout M.A. (2002) Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science, 296, 151–155.
   PubMed Web of Science ®Google Scholar
• Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. (2000) Vascular-speci?c growth factors and blood vessel formation. Nature, 407, 242–248.
   PubMed Web of Science ®Google Scholar
• Yilmaz A., Bieler G., Spertini O., Lejeune F.J., and R¨uegg C. (1998) Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology. International Journal of Cancer, 77, 592–599.
   PubMed Web of Science ®Google Scholar
• Yoganathan T.N., Costello P., Chen X., Jabali M., Yan J., Leung D., Zhang Z., Yee A., Dedhar S., and Sanghera J. (2000) Integrin-linked kinase (ILK): A “hot” therapeutic target. Biochemical Pharmacology, 60, 1115–1119.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y., Dhanabal M., Griffoen A.W., Sukhatme V.P., and Ramakrishnan S. (2000) Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth. Cancer Research, 60, 2190–2196.
   Google Scholar
• Zetter B.R.. (1998) Angiogenesis and tumor metastasis. Annual Review of Medicine, 49, 407–424.
   Google Scholar
• Zhang Z., Vuori K., Reed J.C., and Ruoslahti E. (1995) The alpha 5 beta 1 integrin supports survival of cells on ?bronectin and up-regulates Bcl-2 expression. Proceedings of the National Academy of Science USA, 92, 6161–6165.
   PubMed Web of Science ®Google Scholar